Regeneron cholesterol drug faces sudden challenge
March 26, 2012 at 11:30 AM EDT
CHICAGO, March 26 (Reuters) - A new type of drug being developed by Regeneron Pharmaceuticals Inc slashed levels of cholesterol almost in half when given every four weeks, but fell short of reductions reported a day earlier with once-monthly injections of Amgen Inc's rival product.